Potential role of bcl-2 as a suppressor of tumour angiogenesis in non- small-cell lung cancer

International Journal of Cancer

Volumn 74, Issue 6, 1997, Pages 565-570

  Koukourakis, Michael I ^a,b   Giatromanolaki, Alexandra ^a,b   O'Byrne, Kenneth J ^a   Whitehouse, Ruth M ^a   Talbot, Denis C ^a   Gatter, Kevin C ^a   Harris, Adrian L ^a,c  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL OF IRAKLION   (Greece)

^c CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN BCL 2; PROTEIN P53; TYROSINE KINASE RECEPTOR;

ADULT; AGED; ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER GRADING; CANCER GROWTH; FEMALE; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG CANCER; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

AGED; ANALYSIS OF VARIANCE; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; GENE EXPRESSION; GENES, BCL-2; GENES, P53; GENES, TUMOR SUPPRESSOR; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031471135     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19971219)74:6<565::AID-IJC1>3.0.CO;2-S     Document Type: Article

References (34)

1. BOISE, L.H., GONZALEZ-GARCIA, M., POSTEMA, C.E., DING, L., LINDSTEN, T., TURKA, L.A., MAO, X., NUNEZ, G. and THOMPSON, C.B., Bcl-x, a bcl-2-related gene that functions as a dominant regulator of upoptotic cell death. Cell, 74, 597-608 (1993).
2. CAPLAN, M.S., HEDLUND, E., HILL, N. and MAXKENDRICK, W., The role of endogenous nitric oxide and plattelet-activating factor in hypoxia-induced intestinal injury in rats. Gastroenterology, 106, 346-352 (1994).
3. CORBETT, I.P., HENRY, J.A., ANGUS, B., WATCHORN, C.J., WILKINSON, L., HENNESSY, C., GULLICK, W.J., Tuzi, N.L., MAY, F.E., WESTLEY, B.R., and HORNE, C.H.W. NCL-CB11, a new monoclonal antibody recognising the internal domain of the c-erbB-2 oncogene protein effective for use on formalin-fixed, paraffin-embedded tissue. J. Pathol., 161, 15-25 (1990).
4. DAMERON, K.N., VOLPERT, O.V., TAINSKY, M.A. and BOUCK, N., Control of angiogonesis in fibroblasts by p53 regulation of thrombospondin-1. Science, 265, 1582-1584 (1994).
5. DE-PORTER, C.R., EECKHOUT, I., SCHELFHOUT, A.M., GEERTS, M.L. and ROELS, H.J., Keratinocyte-induced chemotaxis in the pathogenesis of Paget's disease of the breast. Histopathology, 24, 349-356 (1994).
6. FONTANINI, G., VIGNATI, S., BIGINI, D., MUSSI, A., LUCCHI, M., ANGELETTI, C.A., BASOLO, F. and BEVILACQUA, G., bcl-2 protein: a prognostic factor inversely correlated to p53. Brit. J. Cancer, 71, 1003-1007 (1995).
7. GARCIA, I., MARTINOU, I., TSUJIMOTO, Y. and MARTINOU, J.C., Prevention of programmed cell death of sympathetic neurones by the bcl-2 protooncogne. Science, 258, 302-304 (1992).
8. GIATROMANOLAKI, A., GORGOULIS, V., CHETTY, R., KOUKOURAKIS, M.I., WHITEHOUSE, R., KITTAS, C., VESLEMES, M., GATTER, K.C. and IORDANOGLOU, I., c-erbB-2 oncoprotein expression in operable non-small-cell lung cancer. Anti-cancer Res., 16, 987-994 (1996a).
9. GIATROMANOLAKI, A., KOUKOURAKIS, M., O'BYRNE, K., FOX, S., WHITEHOUSE, R., TALBOT, D.C., HARRIS, A.L. and GATTER, K.C., Prognostic value of angiogenesis in operable non-small-cell lung cancer. J. Pathol., 179, 80-88 (1997b).
10. HENNET, T., BERTONI, G., RICHTER, C. and PETERHANS, E., Expression of bcl-2 protein enhances the survival of mouse fibrosarcoid cells in tumor-necrosis-factor-mediated cytotoxicity. Cancer Res., 53, 1456-1460 (1993).
11. HORAK, E.R., RUSSEL, L., KLENK, N., LEJEUNE, S., SMITH, K., STUART, N., GREENALL, M., STEPNEWSKA, K. and HARRIS, A.L., Angiogenesis, assessed by platelet/endothelial-cell-adhesion-molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet, 340, 1120-1124 (1992).
12. JOENSUU, H., PYLKKANEN, L. and TOIKKANEN, S., bcl-2 protein and long-term survival in breast cancer. Amer. J. Pathol., 145, 1191-1198 (1994).
13. KAJSTURA, J., CHENG, W., REISS, K., CLARK, W.A., SONNENBLICK, E.H., KRAJEWSKI, S., REED, J.C., OLIVETTI, G. and ANVERSA, P., Apoptotic and necrotic myocyte-cell deaths are independent contributing variables of intarct size in rats. Lab. Invest., 74, 86-107 (1996).
14. KANE, D.J., SARAFIN, T.A., AUTON, S., HAHN, H., GRALLA, F.B., VALENTINE, J.C., ORD, T. and BREDESEN, D.E., bcl-2 inhibition of neural-cell death: decreased generation of reactive oxygen species. Science, 262, 1274-1276 (1993).
15. KIESER, A., WEICH, H.A., BRANDNER, G., MARME, D. and KOLCH, W., Mutant p53 potentiates protein-kinase-C induction of vascular endothelial-growth-factor expression. Oncogene, 9, 963-969 (1994).
16. KRAJEWSKI, S., KRAJEWSKA, M., SHABALK, A., MIYASHITA, T., WANG, H.G. and REED, J.C., Immunohistochemical determination of in vivo distribution of bax, a dominant inhibitor of bcl-2. Amer. J. Pathol., 145, 1323-1336 (1994).
17. KRAJEWSKI, S., TANAKA, S., TAKAYAMA, S., SCHIBLER, M.J., FENTON, W. and REED, J.C., Investigations of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum and outer mitochondrial membrane. Cancer Res., 53, 4701-4714 (1993).
18. LEEK, R.D., KAKLAMANIS, L., PEZZELLA, F., GATTER, K.C. and HARRIS, A.L., bcl-2 in normal human breast and carcinoma, association with oestrogen-receptor-positive, epidermal-growth-factor-receptor-negative tumours and in situ cancer. Brit. J. Cancer, 69, 135-139 (1994).
19. MCLAREN, R., KUZU, I., DUNNIL, M., HARRIS, A.L., LANE, D. and GATTER, K.C., The relationship of p53 immunostaining to survival in carcinoma of the lung. Brit. J. Cancer, 66, 735-738 (1992).
20. MISAO, J., HAYAKAWA, Y., OHNO, M., KATO, S., FUJIWARA, T. and FUJIWARA, H., Expression of bcl-2 protein, an inhibitor of apoptosis, and bax, an accelerator of apoptosis, in ventricular myocytes of human hearts with mycoardial infarction. Circulation, 94, 1506-1512 (1996).
21. MURPHY, A.N., BREDESEN, D.E., CORTOPASSI, G., WANG, E. and FISKUM, G., bcl-2 potentiates the maximal calcium-uptake capacity of neural-cell mitochondria. Proc. Nat. Acad. Sci. (Wash.) 93, 9893-9898 (1996).
22. NAKAMURA, S., AKAZAWA, K., KINUKAWA, N., YAO, T. and TSUNEYOSHI, M., Inverse correlation between the expression of bcl-2 and p53 proteins in primary gastric lymphoma. Hum. Pathol., 27, 225-233 (1996).
23. OCHIAI, A., AKIMOTO, S., KANAI, Y., SHIBATA, T., OYAMA, T. and HIROHASHI, S., c-erbB-2-gene product associates with catenins in human cancer cells. Biochem. biophys. Res. Commun., 205, 73-78, (1994).
24. PEZZELLA, F., TURLEY, H., KUZU, I., TUNGEKAR, M.F., DUNNILL, M.S., PIERCE, C.B., HARRIS, A., GATTER, K. and MASON, D.Y., bcl-2 protein in non-small-cell lung carcinoma. New Engl. J. Med., 329, 690-694 (1993).
25. POTTEN, C.S., MERRITT, A., HICKMAN, J., HALL, P. and FARANDAY, A., Characterisation of radiation-induced apoptosis in the small intestine and its biological implications. Int. J. Radiat. Biol., 65, 71-78 (1994).
26. QUIRKE, P., PICKLES, A., TUZI, N.L., MOHAMDEE, O. and GULLICK, W.J., Patterns of expression of c-erbB-2 oncoprotein in human fetuses. Brit. J. Cancer, 60, 64-69 (1989).
27. REID, L., The embryology of the lung. In: A.V.S. De Reuck and R. Porter (eds.), Development of the lung. Ciba Foundation Symposium. pp. 109-124, Little, Brown, Boston (1967).
28. RYAN, J.J., PROCHCOWNIK, E., GOTTLIEB, C.A., APEL, I.J., MERINO, R., NUNEZ, G. and CLARKE, M.F., c-myc and bcl-2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle. Proc. Nat. Acad. Sci. (Wash.), 91, 5878-5882 (1994).
29. SHOJI, S., ERTL, R.F., LINDER, J., ROMBERGER, D.J. and RENNARD, S.I., Bronchial epithelial cells produce chemotactic activity for bronchial epithelial cells. Possible role for fibronectin in airway repair. Amer. Rev. Respir. Dis., 141, 218-225 (1990).
30. SILVKSTRINI, R., BENINI, E., VENERONI, S., DAIDONE, M.G., TOMASIC, G., SQUICCIARINI, P. and SALVADORI, B., p53 and bcl-2 expression correlates with clinical outcome in a series of node-positive breast-cancer patients. J. Clin. Oncol., 14, 1604-1610 (1996).
31. TUNGEKAR, M.F., GATTER, K.C., DUNNIL, M.S. and MASON, D.Y., Ki-67 immunostaining and survival in operable lung cancer. Histopathology, 19, 545-550 (1991).
32. VEALE, D., ASCHROFT, T., GIBSON, G.J. and HARRIS, A.L., Epidermal-growth-factor receptors in non-small-cell lung cancer. Brit. J. Cancer, 55, 513-516 (1987).
33. WALKER, C., ROBERTSON, L., MYSKOW, M. and DIXON, G., Expression of the bcl-2 protein in normal and dysplastic bronchial epithelium and in lung carcinomas. Brit. J. Cancer, 72, 164-169 (1995).
34. YONICH-ROUACH, E., RESNITZKY, D., LOTEM, J., SACHS, L., KIMCHI, A. and OREN, M., Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature (Lond.), 252, 345-347 (1991).